Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal

Míreanna comhchosúla

• Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.
  de réir: Latimer, N, et al.
  Foilsithe / Cruthaithe: (2014)
• Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
  de réir: Guerry, M, et al.
  Foilsithe / Cruthaithe: (2012)
• Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
  de réir: Flossmann, O, et al.
  Foilsithe / Cruthaithe: (2006)
• Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis
  de réir: Michael A Paley, et al.
  Foilsithe / Cruthaithe: (2019-01-01)
• Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
  de réir: Robson, J, et al.
  Foilsithe / Cruthaithe: (2017)